Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
about
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Quantitation of [5-14CH3]-(2R, 4'R, 8'R)-α-tocopherol in humans.Future therapeutic directions in reverse cholesterol transport.Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome.Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome.Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes.How can high-throughput screening deliver drugs to treat atherosclerosis?ApoA-I-Directed Therapies for the Management of Atherosclerosis.Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.PPAR-α agonists are still on the rise: an update on clinical and experimental findings.Tert-butylhydroquinone reduces lipid accumulation in C57BL/6 mice with lower body weight gain.
P2860
Q30241952-1E62457F-18A5-4C63-9B75-77717FA8B286Q35112083-4820B28B-49F0-41D5-9B35-E5DE66765A23Q35860010-6DFCD5A6-BE2C-4BBD-B065-D27A42E4D392Q36278286-D6811245-265D-466C-91CB-759E7F6EE061Q37900938-3A5546AF-03ED-4AF3-AC43-C5A80058AF50Q37992593-BFA3C25C-2CA0-4858-AB65-81BD1A2F6517Q38028514-9139DDEA-A604-4B73-8729-EF7E2663214CQ38579703-7A3D1B40-5F0A-4EB7-B618-14510201F2C7Q38835960-A5E4F7C8-9A2A-4AD1-A6DA-C43EC547AF7EQ39200940-B8C0F89A-06A7-4DBA-95D7-DC30105EC4B2Q47241514-4EB2E366-7691-4784-B7CF-2EFB7612AAA0
P2860
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@en
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@nl
type
label
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@en
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@nl
prefLabel
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@en
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@nl
P2093
P2860
P1476
Potent and selective PPAR-alph ...... s with the metabolic syndrome.
@en
P2093
Ashish Shah
Cynthia J Harris
Daniel C Howey
Daniel J Rader
Danielle Duffy
Ilia V Fuki
John S Millar
LeAnne T Bloedon
Mary McCoy
Megan L Wolfe
P2860
P304
P356
10.1161/ATVBAHA.108.171223
P407
P577
2008-11-06T00:00:00Z